Skip to main content

Novel in Vitro Culture and Ultrastructural Techniques to Study the Biology of Myelodysplastic Syndromes (MDS)

  • Chapter
Book cover Myelodysplastic Syndromes & Secondary Acute Myelogenous Leukemia

Part of the book series: Cancer Treatment and Research ((CTAR,volume 108))

Abstract

MDS is a heterogeneous clonal stem cell disorder with trilineage dysplasia resulting in ineffective, monoclonal hematopoiesis ([Resegotti et al., 1993]). Extensive studies over the decade have led to better understanding of cell proliferation, differentiation, cytokine production and apoptosis in MDS ([Greenburg et al., 1987]; [Shetty et al., 1996]; [Clark et al., 1990]; [Yoshida et al., 1993]; [Raza et al., 1995]). However there has been limited information in the literature regarding long term bone marrow cultures and ultrastructural studies performed on MDS. In the past, it has been difficult to grow MDS bone marrow (BM) cells as the progenitor cells have a great propensity to undergo programmed cell death ([Ohmori et al., 1991]; [Aizawa et al., 1999]; [Raza et al., 1996]). On the other hand the role of electron microscopy has not been clearly established in MDS either, other than few individual cases on BM aspirate because of the failure to overcome the technical impediment of maintaining the ultrastructural details in decalcified tissues ([Guccion et al., 1992]; [Gerrad et al., 1992]; [Cohen et al., 1997]; [Payne et al., 1987]). As a result very little is known about the association between the hematopoietic cells and their microenvironment especially in a disease like MDS where both the parenchymal and stromal cells may be involved in the disease process ([Coutinho et al., 1990]; [Sawada et al., 1998])). The present chapter focuses on novel techniques where primarily the MDS core bone marrow biopsy was used to maintain long term bone marrow cultures followed by ultrastructural studies, hence preserving the BM architecture and the geographical distribution of the hematopoietic and stromal cells as they existin vivo.A number of novel and interesting observations were made which are summarized here.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Aizawa, S., Nakano, M., Iwase, O., Yaguchi, M., Hiramoto, M., Hoshi, H., Nabeshima, R., Shima, D., Banda, H., & Toyama, K, (1999) Bone marrow stroma from refractory anemia of myelodysplastic syndrome is defective in its ability to support normal CD34-positive cell proliferation and differentiation in vitro.Leukemia Research23, 239–246.

    Article  PubMed  CAS  Google Scholar 

  • Alvi, S., Shaher, A., Henderson, B., Dar, S., Zorat, F., Broderick, E., Lisak, L., Du Randt, M., Reddy, P., Mundle, S., Galili, N., Borok, R.Z., & Raza, A, (2000) Improved growth of stromal cells in long term bone marrow cultures (LTBMC) of myelodysplastic syndrome (MDS) patients treated with thalidomide.Blood96, 359a. Abstract #1547.

    Google Scholar 

  • Bennett, J.M., Catovsky, D., Flandrin, D.M.T., Galton, G.D.A.G., Gralnick, H.R., & Sultan, C., (1982) Proposal for the classification of the myelodysplastic syndromes.British Journal of Haematology51,189–199.

    PubMed  CAS  Google Scholar 

  • Blazsek, I., Liu, X.H., Anjo, A., Quittet, P., Comisso, M., Kim-Triana, B & Misset, J.L, (1995) The hematon, a morphogenetic functional complex in mammalian bone marrow, involves erythroblastic islands and granulocytic cobblestones.Experimental Hematology23, 309–319.

    PubMed  CAS  Google Scholar 

  • Bogdanovic, A.D., Jankovic, G.M., Colovic, M.D., Trpinac, D.P., & Bumbasirevic, V.Z, (1996) Apoptosis in bone marrow of myelodysplastic syndrome patients.Blood87, 3064.

    PubMed  CAS  Google Scholar 

  • Bouscary, D., De Vos, J., Guesnu, M., Jondeau, K., Viguier, F., Melle, J., Picard, F., Dreyfus, F., & Fontenay-Roupie, M, (1997) Fas/Apo-1 (CD95) expression and apoptosis in patients with myelodysplastic syndromes.Leukemia 11839–845.

    Article  PubMed  CAS  Google Scholar 

  • Chang, J., & Dexter, T.M. (1991) Long—term cultures: in vitro purging of leukemic cells.Baillieres Clinical Haematology3:775–788.

    Article  Google Scholar 

  • Clark, D.M., & Lampert, I.A., (1990) Apoptosis is a common histopathological finding in myelodysplasia: the correlate of ineffective hematopoiesis.Leukemia Research2, 415–418.

    Google Scholar 

  • Cohen, A., Alexandrova, S., Kessler, H., Mittelman, M., Cycowitz, Z.&Djaldetti, M, (1997) Ultrastructural observation on bone marrow cells of 26 patients with myelodysplastic syndromes.Leukemia &Lymphoma27, 165–172.

    CAS  Google Scholar 

  • Coutinho, L.H., Geary, C.G., Chang, J., Harrison, C., & Testa, N.G, (1990) Functional studies of bone marrow haemopoietic and stromal cells in the myelodysplastic syndromes (MDS).British Journal of Haematology75, 16–25.

    Article  PubMed  CAS  Google Scholar 

  • Davey, F. R., Erber, W. N., & Gatter, K.C., (1988) Abnormal neutrophils in acute leukemia and myelodysplastic syndrome.Human Pathology19, 454–459.

    Article  PubMed  CAS  Google Scholar 

  • Dexter, T.M, (1979) Haemopoiesis in long term bone marrow cultures.Acta Haematologia62, 299–305.

    Article  CAS  Google Scholar 

  • Diana, C., Dominici, M., Lanza, F., Punturieri, M., Pauli, S., Tieghi, A., Dabusti, M., Scapoli, G., & Castoldi, G, (2000) Impairment of stromal cells compartment in hypoplastic myelodysplastic syndromes.Blood96, 357a. Abstract # 1541.

    Google Scholar 

  • Duhrsen, U., & Hossfeld, D.K, (1996) Stromal abnormalities in neoplastic bone marrow diseases.Annals ofHematology 7353–70.

    Article  CAS  Google Scholar 

  • Gerrad, J.M., & McNicol, A, (1992) Platelet storage pool deficiency, leukemia, and myelodysplastic syndromesLeukemia & Lymphoma8, 277–281.

    Article  Google Scholar 

  • Gidali, J., Feher, I & Hollan, S.R, (1996) Blast colony forming cell-binding capacity of bone marrow stroma from myelodysplastic patients.Stem Cells14, 577–583.

    Article  PubMed  CAS  Google Scholar 

  • Greenburg, P.L, (1992) In vitro marrow culture studies in the myelodysplastic syndromes.Seminars in Oncology1, 34–46.

    Google Scholar 

  • Greenburg, P.L. (1987) Biologic nature of the myelodysplastic syndromes.Acta Haematologica78, 94–99.

    Article  Google Scholar 

  • Guccion, J.G., Schechter, G.P., & Zeller, J, (1992) Cytomembranous inclusions in myelodysplastic syndromes.Ultrastructural Pathology16, 521–527.

    Article  PubMed  CAS  Google Scholar 

  • Kouides, P.A., & Bennett, J.M, (1992) Morphology and classification of myelodysplastic syndromes [review].Hematology Oncology Clinics of North America6, 485–499.

    CAS  Google Scholar 

  • Lanotte, M., Allen, T.D., & Dexter, M.T., (1981) Histochemical and ultrastructural characteristics of a cell line from human bone marrow stroma.Journal of Cell Science50, 281–297.

    PubMed  CAS  Google Scholar 

  • Lai, J.L., & Fenaux, P, (1997) Cytogenetics of myelodysplastic syndromes.Pathological Biology45, 550–555.

    CAS  Google Scholar 

  • Lepelley, P., Campergue, L., Grardel, N., Preudhomme, C., Cosson, A., Fenaux, P, (1996) Is apoptosis a massive process in myelodysplastic syndromes?British Journal of Haematology95, 368–371.

    Article  PubMed  CAS  Google Scholar 

  • Ohmori, M., Ohmori, S., Ueda, Y., Yoshida, Y., & Okuma, M, (1991) Ineffective hematopoiesis in myelodysplastic syndromes (MDS) as studied by daily in situ observation of colony-cluster formation.International Journal of Cell Cloning9, 521–530.

    Article  PubMed  CAS  Google Scholar 

  • Payne, C.M., Greenberg, B., Cromey, D., & Woo, L, (1987) Morphological evidence of an altered bone marrow microenvironment in patients with acute nonlymphoblastic leukemia and myelodysplastic disorders.Experimental. Hematology15, 143–153.

    PubMed  CAS  Google Scholar 

  • Parcharidou, A., Raza, A., Economopoulos, T., Papageorgiou, E., Anagnostou, D., Papadaki, T., & Raptis, S, (1999) Extensive apoptosis of bone marrow cells as evaluated by in situ end-labeling (ISEL) technique may be the basis for ineffective haematopoiesis in patients with myelodysplastic syndromes.European Journal of Haematology62, 19–26.

    Article  PubMed  CAS  Google Scholar 

  • Pedersen-Bjergaard, J., Philip, P., Larsen, S.O., Anderson, M., Daugaard, G., Ersboll, J., Hansen, S.W., Hou-Jensen, K., Nielsen, D., Sigsgaard, T.C., Specht, L., & Osterlind, K, (1993) Therapy related myelodysplastic syndromes and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series.Leukemia7, 1975–1986.

    PubMed  CAS  Google Scholar 

  • Polli, N., O’Brien M., Tavares, de., Castro, J., Matutes, E., San Miguel, J.F., & Catovsky, D, (1995) Characterization of blast cells in chronic granulocytic leukemia in transformation, acute myelofibrosis and undifferentiated leukemia. 1. Ultrastructural Morphology and Cytochemistry.British. Journal Haematology59, 277–296.

    Article  Google Scholar 

  • Raza, A., Mundle, S., Iftikhar, A., Gregory, S., Marcus, B., Khan, Z., Alvi, S., Shetty, V., Dameron, S., Wright, V., Adler, S., Loew, J., Scott, S., Ali, S.N., & Preisler, H.D., (1995) Simultaneous assessment of cell kinetics and programmed cell death in bone marrow biopsies of myelodysplastics reveals extensive apoptosis as the probable basis for ineffective hematopoiesis.American Journal of Hematology48, 143–154.

    Article  PubMed  CAS  Google Scholar 

  • Raza, A., Gezer, S., Mundle, S., Gao, X.Z., Alvi, S., Borok, R., Rifkin, S., Iftikhar, A., Shetty, V., Parcharidou, A., Loew, J., Marcus, B., Khan, Z., Chaney, C., Showel, J., Gregory, S., & Preisler, H.D, (1996) Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. Blood86, 268–276.

    Google Scholar 

  • Raza, A., Alvi, S., Borok, R.Z., Span, L., Parcharidou, A., Alston, D., Rifkin, S., Robin, E., Shah, R., & Gregory, S.A, (1997).Excessive proliferation matched by excessive apoptosis in myelodysplastic syndromes: The cause-effect relationship.Leukemia & Lymphoma27(1–2), 111–118.

    CAS  Google Scholar 

  • Resegotti, L., (1993) The nature and natural history of myelodysplasia.Haematologia25, 191–204.

    PubMed  CAS  Google Scholar 

  • Sawada, K, (1998) Growth characteristics of myelodysplastic CD34+ cells.Leukemia & Lymphoma„29, 49–60.

    Article  CAS  Google Scholar 

  • Seed, T.M., Husseini, S.G., & Knospe, W.H, (1986) Hematopoiesis on cellulose ester membranes: VII. Ultrastructure of stroma of marrow enriched membranes with trilineal hematopoiesis.Experimental Hematology14, 108–118.

    PubMed  CAS  Google Scholar 

  • Shetty, V., Mundle, S, Alvi, S., Showel, M., Broady-Robinson, L., Dar, S., Borok, R., Showel, J., Greagory, S., Rifkin, S., Gezer, S., Parcharidou, A., Venugopal, P., Shah, R., Hernandez, B., Klein, M., Alston, D., Robin, E., Dominguez, C.&Raza, A, (1996) Measurement of apoptosis, proliferation and three cytokine in 46 patients with myelodysplastic syndromes.Leukemia Research20, 891–900.

    Article  PubMed  CAS  Google Scholar 

  • Vallespi, T., Imbert, M., Mecucci, C., Preudhomme, C., & Fenaux, P, (1998) Diagnosis, classification, and cytogenetics of myelodysplastic syndromes.Haematologica83, 258–275.

    PubMed  CAS  Google Scholar 

  • Verhoef, G.E.G, Pittaluga, S., De Wolf- Peters, C., & Boogaerts, M.A., (1995) FAB classification of myelodysplastic syndromes: merits and controversies.Annals of Hematology71, 3–11.

    Article  PubMed  CAS  Google Scholar 

  • Weimar, I. S., Bourhis, J.H., De Gast, G.C., & Gerritsen, W.R, (1994) Clonality in myelodysplastic syndromes.Leukemia & Lymphoma13, 215–221.

    Article  CAS  Google Scholar 

  • Weiss, L., (1976) The hematopoietic microenvironment of the bone marrow: An ultrastructural study of the stroma in rat.Anatomica. Records186, 161–184.

    Article  CAS  Google Scholar 

  • Yoshida, Y., (1993) Apoptosis may be the mechanism responsible for the premature intramedullary cell death in myelodysplastic syndromes.Leukemia7, 144–146.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer Science+Business Media New York

About this chapter

Cite this chapter

Alvi, S., Lisak, L.A., Shetty, V.T. (2001). Novel in Vitro Culture and Ultrastructural Techniques to Study the Biology of Myelodysplastic Syndromes (MDS). In: Raza, A., Mundle, S.D. (eds) Myelodysplastic Syndromes & Secondary Acute Myelogenous Leukemia. Cancer Treatment and Research, vol 108. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1463-3_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-1463-3_4

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-5566-3

  • Online ISBN: 978-1-4615-1463-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics